Investment
Participated in TYBR Health's $30M Series A financing to expand access to the B3 GEL System.
TYBR Health
AUG 12, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
TYBR Health
Kevin Rocco on the medtech M&A landscape at LSX World Congress USA
Nick Pachuda and Kevin Rocco on Orthopedics This Week: Diligence Done the Right Way
Investing in Orthopedic Startups
Biorez